How Hong Kong plays a central role in the biotech investment boom

While many industries have struggled through the COVID-19 pandemic, the global biotech sector has gone from strength to strength, with Hong Kong helping to lead the way.

Nisa Leung, Managing Partner of Qiming Venture Partners and Dr Alex Zhavoronkov, founder and CEO of Insilico Medicine point to the HKEX’s listing reform and Hong Kong’s strategic position in the Greater Bay Area.

Learn more at the Asia Summit on Global Health: https://www.asiasummitglobalhealth.com

#ASGH #ASGHHK #Healthcare #Innovation #Investment

source